Clinical Trial of the Efficacy and Safety of AC0010 in the Treatment of EGFR T790M Patients With Advanded NSCLC
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03300115 |
|
Recruitment Status : Unknown
Verified February 2019 by Hangzhou ACEA Pharmaceutical Research Co., Ltd..
Recruitment status was: Recruiting
First Posted : October 3, 2017
Last Update Posted : February 19, 2019
|
Sponsor:
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Collaborator:
Guangdong Provincial People's Hospital
Information provided by (Responsible Party):
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | June 17, 2019 |
| Estimated Study Completion Date : | December 17, 2020 |